Radiology workflow software program firm Sirona Medical has obtained $42 million in Collection C financing, bringing complete funding raised to $100 million. The corporate additionally named a brand new CEO.
Avidity Companions, a participant within the beforehand introduced Collection B financing, led this spherical with extra participation from different current buyers, together with 8VC, and GreatPoint Ventures.
San Francisco-based Sirona stated its Unify platform unifies diagnostic and medical picture viewing, radiology reporting, worklist, and AI (together with impression technology) on a single cloud-native platform.
The Unify platform will be deployed as an overlay to current on-premises techniques (PACS and RIS), permitting radiology practices that service a number of hospitals and well being techniques to mix disparate workflows right into a single unified workflow expertise.
The brand new capital will help business enlargement in addition to the continued evolution of the Unify platform, notably round workflow effectivity and AI-powered report technology.
Hooman Hakami, who has served as a senior government at GE Healthcare and Medtronic, has been appointed CEO. Cameron Andrews, Sirona’s founder, will stay concerned in his new function as president.
“We’re coming into the following part within the firm’s maturity and talent to ship our next-generation answer to a broader viewers whereas supporting the success of each buyer,” stated Andrews, in an announcement.
“The Sirona imaginative and prescient is compelling. Cameron and the whole staff have accomplished a superb job attaining a stage of workflow integration throughout a number of platforms that no different firm has reached in radiology IT. I stay up for working alongside Cameron and the whole Sirona staff as we enter this new development part,” stated Hakami in an announcement.
Sirona Medical is led by a staff of software program engineers, knowledge scientists, and radiology professionals together with Alan Kaye, M.D., chief medical officer and former president of the American School of Radiology (ACR), in addition to trade veterans from Sectra, Arterys, R2 Applied sciences, and others. Notable advisors embody Curt Langlotz, M.D., Ph.D., director on the Heart for Synthetic Intelligence in Medication and Imaging (AIMI) at Stanford College; Chris Wooden, former CTO at Intelerad; Ron Paulus, former CEO at Mission Well being, and; Bob Baumgartner, retired government chairman of the board on the Heart for Diagnostic Imaging.